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Autoimmune thyroid disease in northern Iranian children  
with type 1 diabetes mellitus in Amirkola Endocrine Clinic 
 
Abstract: 
Background: Type 1 diabetes mellitus (T1DM) as an autoimmune disorder is 
associated with other autoimmune diseases such as autoimmune thyroid (AIT) 
disease. The aim of this study was to determine the prevalence of AIT in children 
who were referred to Amirkola Endocrine Clinic (north of Iran). 
Methods: This cross-sectional study was carried out on 100 diabetic children aged 
1-15 years during 2008-2013, who were referred to the pediatric endocrine clinic. 
Serum levels of anti-thyroid peroxidase (Anti-TPO) and anti-thyroglobulin (anti-
Tg) antibodies and Thyrotropin Stimulating Hormone (TSH) were measured by 
Immune Chemiluminescence assay, and demographic information was obtained 
from patients'medical records. The collected data were analyzed using SPSS 18. 
Results: AIT was found in 13% of patients (8% female and 5% male). Significant 
levels were found for Anti-TPO (3%), anti-Tg (2%), and both antibodies (8%) in 
patients with AIT. Thyroid dysfunction was observed in 8 of 13 patients with AIT 
versus 2 of 87 patients without AIT (P<0.001). AIT was seen in 9% of diabetic 
children who had diabetes for less than one year versus 4% of the rest of diabetic 
children with duration more than one year (p<0 .0001).  
Conclusion: Because the majority of diabetic children with significant titers of 
antibodies developed thyroid disease, so thyroid function tests are necessary to 
reduce the risk of undiagnosed hypothyroidism in these patients. 
Key Words: Anti Thyroid Peroxidase Antibody, Anti-Thyroglobulin Antibody, 
Autoimmune Thyroid Disease, Hypothyroidism, Type 1 Diabetes Mellitus. 
 
 
 
 
 
 
Introduction: 
The association between type 1 diabetes mellitus (T1DM) and other 
autoimmune diseases, particularly autoimmune thyroid disease (AIT)  has been 
reported in many populations 
[1, 2]
. The prevalence of positive thyroid autoimmune 
antibodies in children with T1DM varies considerably from 3% to 50% in different 
countries 
[3, 4]
, whereas there is low prevalence of autoimmune thyroiditis, 3.4-4.5% 
in general population 
[5]
. The AIT includes variable degrees of lymphocytic 
infiltrations of the thyroid gland and this process is an important source of thyroid 
autoantibody production, along with the surrounding lymph nodes and bone 
marrow. Chronic autoimmune thyroiditis (Hashimoto’s thyroiditis) and Graves’ 
disease are the major causes of hypothyroidism and hyperthyroidism, respectively 
[6]
. Up to now, there is no consensus neither on screening for autoimmune 
thyroiditis nor the time point of therapeutic intervention in children with T1DM 
unless clinical symptoms of thyroid dysfunction appear 
[3, 4]
. Because of the high 
association between AIT and thyroid dysfunction in patients with T1DM and also 
probable effects on glycemic control and lack of enough information and 
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studies on AIT and thyroid dysfunction in diabetic 
children in our area (north of Iran), we investigated the 
prevalence of AIT antibodies in children with T1DM. 
 
 
Methods: 
This respective and cross-sectional study was 
conducted on children with previous T1DM who were 
diagnosed and managed at the pediatric endocrine 
clinic, Amirkola Children's Hospital, from 2008 to 
2013. Eligibility criteria included patients with 1-15 
years old, lack of previous thyroid medication and 
intercurrent illness. Finally, 100 children with T1DM 
were studied during this period that included 52 males 
and 48 females. They were routinely screened for 
autoimmune thyroid antibodies and thyroid 
dysfunction. Anti-TPO and anti-Tg antibodies were 
measured and thyroid dysfunction was determined by 
measurement of TSH and T4.  
Measurement of Anti-TPO, anti-Tg and TSH was 
performed via Immune Chemiluminescence assay 
(MONOBIND kit, Costa Mesa, USA). Values 
exceeding 40 IU/ml and 125 IU/ml for anti-Tg and 
anti-TPO were considered as positive autoimmune 
thyroid antibodies, respectively. The normal range 
determined for TSH was according to the instruction of 
kit, 0.5-5.5 mIU/ml (Iran Kavoshyar Co.,Tehran, Iran). 
Clinical hypothyroidism was defined as elevated TSH 
and low T4, versus subclinical hypothyroidism as 
elevated TSH with normal T4. 
Data were analyzed using SPSS 18 and statistical 
tests including Chi- square, T-test, and Mann-Whitney 
test. Correlations between antibody concentrations and 
TSH values were determined using regression analysis. 
P≤0.05 was considered significant level.  
 
 
Results: 
Screening for thyroid antibodies showed that 13% 
patients had significantly elevated titers of antibodies. 
There was no significant difference in the mean age 
between two groups (p=0.59). Based on the age group, 
18%, 46% and 36% of the patients were 1-5, 5-10 and 
10-15 years old, respectively.  
Thyroid antibodies titers were enhanced with 
increasing age and anti-TPO positive and both anti-
TPO and anti-Tg positive were more common in 10-
15-year-old group but anti-Tg positive was more 
common in the age group 5-10 years old. AIT was 
observed in 16.6% (8/48) of females and 9.6% (5/52) 
of males with female to male ratio of 1.6:1 but the 
difference was not significant (p=0.3). 
A total of 46.2% of diabetic children with AIT had 
abnormal TSH levels compared to 2.3% of diabetic 
children without AIT (p=0.001). The biochemical 
characteristics in diabetic children are illustrated in 
table 1. TSH values were different according to the 
pattern of elevated thyroid antibodies: anti-Tg positive 
with 2.92±1, anti-TPO positive with 16.6±17.39 and 
both anti-TPO and anti-Tg positive with10.59±9 
(IU/ml), but there was no significant difference in 
mean of TSH values among them (p=0.21).  
A significant relationship between the level of TSH 
and anti-TPO (β=0.01, p<0 .0001) (figure 1) but there 
was no significant correlation between the level of 
TSH with anti-Tg (p=0) and a diabetes duration 
(p=0.2). Eight from 13 patients with AIT progressed to 
thyroid dysfunction (one clinical hypothyroidism and 7 
subclinical hypothyroidism) but 2 patients without AIT 
progressed to subclinical hypothyroidism. 
Thyroid dysfunction was observed in 2 of 3 
(66.6%) patients with only anti-TPO positive and 6 of 
8 patients (75%) with both anti-TPO and anti-Tg 
positive (p=0.91). 
AIT was founded in 9% of diabetic children who 
had diabetes for less than one year versus 4% of the 
rest of diabetic children with a diabetes duration of 
more than one year (p=<0 .0001). 
 
 
 
 
Table 1: The biochemical data in diabetic children with or without AIT. 
 
Biochemical data 
Patient with AIT 
Mean ±SD 
Patient without AIT 
Mean ±SD 
P.value 
Anti-TPO titer (IU/ml) 374.76±512.8 8.18±11.1 <0 .0001 
Anti-Tg titer (IU/ml) 376.98±497.2 11.8±8.7 <0 .0001 
TSH (IU/ml) 9.97±10.4 2.81±1.35 0 .001 
T4 (μg/dl) 8.28±1.9 8.57±1.6 0.54 
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Figure 1: The relation between level of TSH and anti-TPO according to scatter plot (r=0.51) 
 
 
Discussion: 
In this study, the prevalence of AIT was 13% in 
children with T1DM. It was reported by Kordonouri 
et.al 10%, severenski 15.5% 
[4, 5]
. Karavanaki et al's 
reported anti-TPO and anti-Tg antibodies positivity in 
17.4 and 11.1% of the patients, respectively, and 7.6% 
of them were positive for both anti-thyroid antibodies 
[7]
, while in our study Anti-TPO, anti-Tg and both 
antibodies were positive in 3, 2 and 8%, respectively. 
A few studies in Iran showed that the prevalence of 
AIT was 9% and 22% in children of Tabriz and 
Isfahan, respectively 
[3, 8]
. The lowest and highest 
prevalence rates of AIT in children and adolescents 
with T1DM were 3.9% in Italy and 50% in USA, but 
many studies represented that the prevalence rates were 
15-20% 
[5]
. A wide variation of AIT prevalence in 
diabetic children could likely be illustrated through the 
difference in genetic factors, different methods for 
detection of thyroid antibodies and sensitivity of 
diagnostic tests 
[8,9]
. 
The results of the present study demonstrated that 
AIT was more prevalent in female than male and was 
nearly two folds while it was not significant, which 
accords with some studies 
[10-13]
. Many studies 
emphasized female gender as a predisposing factor for 
AIT in both diabetic patients and general population 
[5]
. 
On the other hand, the prevalence of T1DM was equal 
between two genders, so more frequent occurrence of 
AIT could be related to the risk factors, exclusive of 
induced causes of diabetes, for example, hormone 
influences 
[2, 5]
. 
Although the prevalence of thyroid antibodies was 
risen with increasing age of the children in the current 
study, it did not reach statistical significance, which 
agrees with that of Araujo et al's 
[2]
. In another study, 
the frequency of positive anti-Tg and anti-TPO was 37 
and 15% during the first year of diabetes diagnosis, 
respectively 
[7]
. In the general population without 
diabetes, the prevalence of thyroid-antibody positivity 
increased with age 
[1, 2, 4]
. The age-dependent increase 
in autoantibody positivity suggests that autoimmune 
disease is the final phase of a process starting with 
autorecognition, passing through immunity with the 
appearance of autoantibodies, and finally leading to 
cell destruction and autoimmune disease 
[14]
  
The current study founded that thyroid antibodies 
were determined in the majority (10/13) of diabetic 
children with duration of less than one year that is 
agreement with some studies 
[5, 9, 12, 13]
. These data 
suggested the importance of screening near to the time 
of diabetes diagnosis. 
Our findings represented that children with TID had 
higher TSH level than without T1DM and the elevated 
anti-TPO associated with higher value of TSH, so it 
seemed that elevated anti-TPO than anti-TG was more 
specific for thyroid dysfunction that is consistent with 
others 
[3, 5, 13, 15-17]
. 
The results of the present study demonstrated that 
thyroid dysfunction developed in 8% of total children 
and 61.5% of diabetic children with AIT, of 
whom53.8% and 7.7% had subclinical and clinical 
hypothyroidism, respectively. So significant difference 
was observed between diabetic children with and 
without AIT, which is agreement with other studies 
 
[2, 3, 5]
. Ardestani et al's explained that 38.8% of diabetic 
patients with AIT had subclinical hypothyroidism 
without any case of clinical hypothyroidism. In many 
researches, it was found that the prevalence rate of 
autoimmune thyroid disease in children with newly 
diagnosed T1DM was 4.5-29.4% 
[9]
. In the present 
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study, AIT in patients who had diabetes for less than 
one year was more common because 5 of 8 patients 
with thyroid dysfunction had diabetes less than one 
year. Limitations of the current study were the small 
sample size of diabetic children to determine the 
prevalence of AIT.  
Moreover, in this retrospective study, the screening 
of TSH, anti-TPO and anti-Tg was not performed 
annually in all patients. Due to the irregular screening 
tests, this disease may be detected with delay, some 
years after development. Therefore, regular testing of 
TSH and auto-antibodies are recommended for patients 
with T1DM. 
According to close association of autoimmune 
thyroid disorders with T1DM in children, evaluation of 
these patients in terms of thyroid function and thyroid 
autoantibodies is suggested to reduce the risk of 
undiagnosed hypothyroidism in these patients. 
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